Symbols / TIVC
TIVC Chart
About
Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus pain, pressure, and congestion. The company sells its products through online retailers and commercial distributors, as well as its own website. Its lead product candidate is Entolimod, a late-stage TLR5 agonist for use in the treatment of acute radiation syndrome. In addition, the company markets its commercial product under the ClearUP Sinus Pain Relief brand name. It also focusses on non-invasive vagus nerve stimulation. The company was incorporated in 2016 and is based in Fremont, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 2.03M |
| Enterprise Value | -2.11M | Income | -7.55M | Sales | 482.00K |
| Book/sh | 3.36 | Cash/sh | 1.95 | Dividend Yield | — |
| Payout | 0.00% | Employees | 7 | IPO | — |
| P/E | — | Forward P/E | -0.03 | PEG | — |
| P/S | 4.22 | P/B | 0.24 | P/C | — |
| EV/EBITDA | 0.28 | EV/Sales | -4.37 | Quick Ratio | 5.44 |
| Current Ratio | 5.86 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -8.00 | EPS next Y | -24.00 | EPS Growth | — |
| Revenue Growth | 15.90% | Earnings | 2023-11-14 16:00 | ROA | -96.20% |
| ROE | -178.18% | ROIC | — | Gross Margin | -58.09% |
| Oper. Margin | -17.01% | Profit Margin | 0.00% | Shs Outstand | 2.53M |
| Shs Float | 1.70M | Short Float | 2.80% | Short Ratio | 0.58 |
| Short Interest | — | 52W High | 13.23 | 52W Low | 0.75 |
| Beta | 1.98 | Avg Volume | 916.63K | Volume | 1.74K |
| Target Price | — | Recom | None | Prev Close | $0.76 |
| Price | $0.81 | Change | 5.92% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.80
Latest analyst target
3. DCF / Fair value
$-25.49
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.80
Low
—
High
—
Mean
—
- US reexamines Tivic radiation sickness drug that boosted survival in animals - Stock Titan Wed, 18 Feb 2026 14
- Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital - TradingView Mon, 09 Feb 2026 08
- Tivic Health (Nasdaq: TIVC) adds CDMO unit to speed Entolimod manufacturing - Stock Titan hu, 11 Dec 2025 08
- Tivic Health Establishes Flexible $50 Million Equity Line - TipRanks Mon, 09 Feb 2026 08
- Tivic Reports Second Quarter 2025 Financial Results - Yahoo Finance hu, 14 Aug 2025 07
- Velocity Bioworks: A Game-Changer for TIVC? - timothysykes.com ue, 23 Dec 2025 08
- Tivic Health stock soars as company advances military radiation countermeasure - Investing.com South Africa Fri, 15 Aug 2025 07
- Tivic to detail in-house Entolimod manufacturing, new revenue streams - Stock Titan ue, 20 Jan 2026 08
- Tivic Health Highlights TLR5 Pipeline in New Investor Presentation - TipRanks ue, 20 Jan 2026 08
- Why Is Tivic Health Systems (TIVC) Stock Down 51% Today - InvestorPlace hu, 09 Feb 2023 08
- Tivic Health Systems, Inc. Announces Reverse Stock Split - Yahoo Finance Wed, 05 Mar 2025 08
- Tivic Health Systems (TIVC) Stock Price, News & Analysis $TIVC - MarketBeat Fri, 12 Nov 2021 01
- Inside Tivic’s push for faster drug making with its new Velocity Bioworks - Stock Titan hu, 08 Jan 2026 08
- Tivic Health Systems (TIVC) Stock Pops Another 39% - InvestorPlace Mon, 29 Jul 2024 07
- TIVC Stock Price and Chart — NASDAQ:TIVC - TradingView hu, 11 Nov 2021 17
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 8824 | — | — | HANDLEY MICHAEL K | Chief Operating Officer | — | 2026-02-18 00:00:00 | D | nan |
| 1 | 736 | — | — | WOLF LISA G | Chief Financial Officer | — | 2025-12-18 00:00:00 | D | nan |
| 2 | 14706 | — | — | ERNST JENNIFER | Chief Executive Officer | — | 2025-12-18 00:00:00 | D | nan |
| 3 | 22541 | — | Stock Award(Grant) at price 0.00 per share. | ERNST JENNIFER | Chief Executive Officer | — | 2025-09-22 00:00:00 | D | — |
| 4 | 7500 | — | Stock Award(Grant) at price 0.00 per share. | BAMBACH KIMBERLY ANN | Chief Financial Officer | — | 2024-03-12 00:00:00 | D | — |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -5.31M | -8.06M | -9.92M | -5.45M |
| TotalUnusualItems | 0.00 | -1.20M | ||
| TotalUnusualItemsExcludingGoodwill | 0.00 | -1.20M | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -5.66M | -8.24M | -10.10M | -8.49M |
| ReconciledDepreciation | 352.00K | 182.00K | 174.00K | 24.00K |
| ReconciledCostOfRevenue | 778.00K | 889.00K | 1.54M | 1.29M |
| EBITDA | -5.31M | -8.06M | -9.92M | -6.65M |
| EBIT | -5.66M | -8.24M | -10.10M | -6.67M |
| NetInterestIncome | 6.00K | 1.00K | 2.00K | -1.82M |
| InterestExpense | 1.82M | |||
| InterestIncome | 6.00K | 1.00K | 2.00K | |
| NormalizedIncome | -5.66M | -8.24M | -10.10M | -7.29M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -5.66M | -8.24M | -10.10M | -8.49M |
| TotalExpenses | 6.44M | 9.42M | 11.94M | 6.89M |
| TotalOperatingIncomeAsReported | -5.66M | -8.24M | -10.10M | -5.63M |
| DilutedAverageShares | 287.37K | 46.65K | 5.69K | 2.05K |
| BasicAverageShares | 287.37K | 46.65K | 5.69K | 2.05K |
| DilutedEPS | -19.68 | -176.80 | -1.77K | -4.13K |
| BasicEPS | -19.68 | -176.80 | -1.77K | -4.13K |
| DilutedNIAvailtoComStockholders | -5.66M | -8.24M | -10.10M | -8.49M |
| NetIncomeCommonStockholders | -5.66M | -8.24M | -10.10M | -8.49M |
| NetIncome | -5.66M | -8.24M | -10.10M | -8.49M |
| NetIncomeIncludingNoncontrollingInterests | -5.66M | -8.24M | -10.10M | -8.49M |
| NetIncomeContinuousOperations | -5.66M | -8.24M | -10.10M | -8.49M |
| TaxProvision | 1.00K | |||
| PretaxIncome | -5.66M | -8.24M | -10.10M | -8.49M |
| OtherIncomeExpense | -1.04M | |||
| OtherNonOperatingIncomeExpenses | 162.00K | |||
| SpecialIncomeCharges | 0.00 | -1.64M | ||
| OtherSpecialCharges | 1.64M | |||
| GainOnSaleOfSecurity | 436.00K | |||
| NetNonOperatingInterestIncomeExpense | 6.00K | 1.00K | 2.00K | -1.82M |
| TotalOtherFinanceCost | -2.00K | |||
| InterestExpenseNonOperating | 1.82M | |||
| InterestIncomeNonOperating | 6.00K | 1.00K | 2.00K | |
| OperatingIncome | -5.66M | -8.24M | -10.10M | -5.63M |
| OperatingExpense | 5.66M | 8.53M | 10.40M | 5.59M |
| ResearchAndDevelopment | 1.31M | 1.66M | 1.73M | 878.00K |
| SellingGeneralAndAdministration | 4.35M | 6.88M | 8.67M | 4.72M |
| SellingAndMarketingExpense | 1.19M | 2.12M | 2.79M | 1.79M |
| GeneralAndAdministrativeExpense | 3.16M | 4.75M | 5.88M | 2.93M |
| OtherGandA | 3.16M | 4.75M | 5.88M | 2.93M |
| GrossProfit | 2.00K | 287.00K | 299.00K | -38.00K |
| CostOfRevenue | 778.00K | 889.00K | 1.54M | 1.29M |
| TotalRevenue | 780.00K | 1.18M | 1.84M | 1.26M |
| OperatingRevenue | 780.00K | 1.18M | 1.84M | 1.26M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 556.98K | 86.24K | 5.69K | 5.71K |
| ShareIssued | 556.98K | 86.24K | 5.69K | 5.71K |
| TotalDebt | 0.00 | 369.00K | 530.00K | 708.00K |
| TangibleBookValue | 2.54M | 3.58M | 3.63M | 13.27M |
| InvestedCapital | 2.54M | 3.58M | 3.63M | 13.27M |
| WorkingCapital | 2.37M | 3.25M | 3.43M | 13.07M |
| NetTangibleAssets | 2.54M | 3.58M | 3.63M | 13.27M |
| CapitalLeaseObligations | 0.00 | 369.00K | 530.00K | 708.00K |
| CommonStockEquity | 2.54M | 3.58M | 3.63M | 13.27M |
| TotalCapitalization | 2.54M | 3.58M | 3.63M | 13.27M |
| TotalEquityGrossMinorityInterest | 2.54M | 3.58M | 3.63M | 13.27M |
| StockholdersEquity | 2.54M | 3.58M | 3.63M | 13.27M |
| RetainedEarnings | -43.54M | -37.89M | -29.64M | -19.55M |
| AdditionalPaidInCapital | 46.08M | 41.47M | 33.27M | 32.82M |
| CapitalStock | 1.00K | 0.00 | 0.00 | 1.00K |
| CommonStock | 1.00K | 0.00 | 0.00 | 1.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 272.00K | 1.58M | 2.25M | 1.76M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 176.00K | 367.00K | 545.00K |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 176.00K | 367.00K | 545.00K |
| LongTermCapitalLeaseObligation | 0.00 | 176.00K | 367.00K | 545.00K |
| CurrentLiabilities | 272.00K | 1.40M | 1.88M | 1.22M |
| CurrentDebtAndCapitalLeaseObligation | 193.00K | 163.00K | 163.00K | |
| CurrentCapitalLeaseObligation | 0.00 | 193.00K | 163.00K | 163.00K |
| PayablesAndAccruedExpenses | 272.00K | 1.21M | 1.72M | 1.06M |
| CurrentAccruedExpenses | 147.00K | 335.00K | 392.00K | 267.00K |
| Payables | 125.00K | 873.00K | 1.32M | 789.00K |
| TotalTaxPayable | 0.00 | 160.00K | ||
| AccountsPayable | 125.00K | 713.00K | 1.32M | 789.00K |
| TotalAssets | 2.81M | 5.16M | 5.88M | 15.04M |
| TotalNonCurrentAssets | 168.00K | 505.00K | 569.00K | 747.00K |
| OtherNonCurrentAssets | 34.00K | 34.00K | 49.00K | |
| NonCurrentDeferredAssets | 49.00K | 0.00 | ||
| NetPPE | 119.00K | 471.00K | 535.00K | 698.00K |
| AccumulatedDepreciation | -40.00K | -37.00K | -29.00K | |
| GrossPPE | 159.00K | 508.00K | 564.00K | 698.00K |
| OtherProperties | 148.00K | 148.00K | 30.00K | 11.00K |
| MachineryFurnitureEquipment | 11.00K | 11.00K | 11.00K | |
| BuildingsAndImprovements | 0.00 | 349.00K | 523.00K | 687.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 2.64M | 4.65M | 5.31M | 14.29M |
| OtherCurrentAssets | 249.00K | 327.00K | 235.00K | 793.00K |
| CurrentDeferredAssets | 0.00 | 584.00K | 0.00 | |
| PrepaidAssets | 834.00K | |||
| Inventory | 319.00K | 756.00K | 863.00K | 429.00K |
| InventoriesAdjustmentsAllowances | -338.00K | -32.00K | 0.00 | 0.00 |
| FinishedGoods | 192.00K | 36.00K | 116.00K | 148.00K |
| WorkInProcess | 5.00K | 0.00 | 23.00K | 0.00 |
| RawMaterials | 460.00K | 752.00K | 724.00K | 281.00K |
| Receivables | 69.00K | 174.00K | 107.00K | 92.00K |
| AccountsReceivable | 69.00K | 174.00K | 107.00K | 92.00K |
| AllowanceForDoubtfulAccountsReceivable | 0.00 | -82.00K | ||
| GrossAccountsReceivable | 88.00K | 174.00K | ||
| CashCashEquivalentsAndShortTermInvestments | 2.00M | 3.40M | 3.52M | 12.97M |
| CashAndCashEquivalents | 2.00M | 3.40M | 3.52M | 12.97M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.72M | -8.63M | -8.93M | -5.61M |
| RepaymentOfDebt | 0.00 | -19.00K | ||
| IssuanceOfDebt | 0.00 | 2.61M | ||
| IssuanceOfCapitalStock | 4.38M | 8.51M | 0.00 | 14.89M |
| CapitalExpenditure | -118.00K | -11.00K | ||
| InterestPaidSupplementalData | 0.00 | |||
| IncomeTaxPaidSupplementalData | 1.00K | |||
| EndCashPosition | 2.00M | 3.40M | 3.52M | 12.97M |
| BeginningCashPosition | 3.40M | 3.52M | 12.97M | 1.04M |
| ChangesInCash | -1.39M | -122.00K | -9.46M | 11.93M |
| FinancingCashFlow | 4.33M | 8.51M | -528.00K | 17.54M |
| CashFlowFromContinuingFinancingActivities | 4.33M | 8.51M | -528.00K | 17.54M |
| NetOtherFinancingCharges | -49.00K | -584.00K | ||
| ProceedsFromStockOptionExercised | 0.00 | 56.00K | 62.00K | |
| NetPreferredStockIssuance | 0.00 | |||
| PreferredStockIssuance | 0.00 | |||
| NetCommonStockIssuance | 4.38M | 8.51M | 0.00 | 14.89M |
| CommonStockIssuance | 4.38M | 8.51M | 0.00 | 14.89M |
| NetIssuancePaymentsOfDebt | 0.00 | 2.59M | ||
| NetLongTermDebtIssuance | 0.00 | 2.59M | ||
| LongTermDebtPayments | 0.00 | -19.00K | ||
| LongTermDebtIssuance | 0.00 | 2.61M | ||
| InvestingCashFlow | 0.00 | -118.00K | -11.00K | 0.00 |
| CashFlowFromContinuingInvestingActivities | 0.00 | -118.00K | -11.00K | 0.00 |
| NetPPEPurchaseAndSale | 0.00 | -118.00K | -11.00K | 0.00 |
| PurchaseOfPPE | 0.00 | -118.00K | -11.00K | 0.00 |
| OperatingCashFlow | -5.72M | -8.51M | -8.92M | -5.61M |
| CashFlowFromContinuingOperatingActivities | -5.72M | -8.51M | -8.92M | -5.61M |
| ChangeInWorkingCapital | -1.00M | -752.00K | 605.00K | -403.00K |
| ChangeInOtherCurrentLiabilities | -369.00K | -161.00K | -178.00K | 4.00K |
| ChangeInOtherCurrentAssets | 34.00K | 0.00 | 15.00K | 0.00 |
| ChangeInPayablesAndAccruedExpense | -936.00K | -507.00K | 643.00K | 547.00K |
| ChangeInAccruedExpense | -348.00K | 103.00K | 109.00K | 128.00K |
| ChangeInPayable | -588.00K | -610.00K | 534.00K | 419.00K |
| ChangeInAccountPayable | -588.00K | -610.00K | 534.00K | 419.00K |
| ChangeInPrepaidAssets | 78.00K | -92.00K | 558.00K | -707.00K |
| ChangeInInventory | 83.00K | 75.00K | -434.00K | -181.00K |
| ChangeInReceivables | 105.00K | -67.00K | 1.00K | -66.00K |
| ChangesInAccountReceivables | 105.00K | -67.00K | 1.00K | -66.00K |
| OtherNonCashItems | 1.82M | |||
| StockBasedCompensation | 229.00K | 271.00K | 398.00K | 57.00K |
| ProvisionandWriteOffofAssets | 354.00K | 32.00K | 0.00 | 58.00K |
| DepreciationAmortizationDepletion | 352.00K | 182.00K | 174.00K | 24.00K |
| DepreciationAndAmortization | 352.00K | 182.00K | 174.00K | 24.00K |
| Depreciation | 352.00K | 182.00K | 174.00K | 24.00K |
| OperatingGainsLosses | 1.32M | |||
| GainLossOnInvestmentSecurities | -156.00K | |||
| NetIncomeFromContinuingOperations | -5.66M | -8.24M | -10.10M | -8.49M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for TIVC
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|